Cite
HARVARD Citation
Kretsos, K. et al. (n.d.). Safety and pharmacokinetics of olokizumab, an anti‐IL‐6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I study. Clinical pharmacology in drug development. 3 (5), pp. 388-395. [Online].